Search

Your search keyword '"Kirsten A. Nyrop"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Kirsten A. Nyrop" Remove constraint Author: "Kirsten A. Nyrop"
139 results on '"Kirsten A. Nyrop"'

Search Results

1. A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects

2. A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer

3. The Effects of 16 Weeks of Exercise Training on Neutrophil Functions in Breast Cancer Survivors

4. Exercise-induced modulation of monocytes in breast cancer survivors

6. Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders

7. Impact of community-based exercise on fatigue in early breast cancer survivors: identifying potential determinants of change

8. Racial disparities in frailty and geriatric assessment impairments in older adults with cancer in the Deep South: Results from the CARE Registry

9. Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status

10. Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers

12. Data from Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer

13. Data from Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy

14. Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer

16. Obesity, Cancer, and Health Equity

17. Measuring quality of life in older people with cancer

18. Myosteatosis evaluation using erector spinae and psoas muscles to predict adverse events during adjuvant chemotherapy for breast cancer

19. Body Mass Index and patient-reported measures of function, quality of life and treatment toxicity in women receiving adjuvant chemotherapy for breast cancer

20. Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma

21. Age and competing concerns in treatment selection for women with non-metastatic HR+ and HER2− breast cancer: Current clinical practice

22. Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer

23. Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer

24. Serial Assessment of Depression and Anxiety by Patients and Providers in Women Receiving Chemotherapy for Early Breast Cancer

25. p16 a biomarker of aging and tolerance for cancer therapy

26. The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer

27. Associations of functional, psychosocial, and medical factors with cognitive impairment in older, chemotherapy naïve patients with early breast cancer

28. Abstract P3-08-73: Muscle measures, body composition, and function in patients with early breast cancer

29. Abstract P3-08-48: Adiposity, comorbidities, and function in patients with early breast cancer

30. A Randomized Trial of Real-Time Geriatric Assessment Reporting in Nonelectively Hospitalized Older Adults with Cancer

31. Physical Activity Intervention in Patients with Metastatic Breast Cancer During Active Treatment: Quality of Life and Function

33. Phase Ib trial of Lenalidomide as Post-Remission Therapy for Older Adults with Acute Myeloid Leukemia: Safety and Longitudinal Assessment of Geriatric Functional Domains

34. Anticipating mental health needs after chemotherapy in early-stage breast cancer using patient-reported symptom screening

35. Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life

36. Baseline fatigue in early breast cancer survivors: understanding its prevalence in community-based exercise

37. Person-centered communication about weight and weight management: Focus group discussions in a diverse sample of women with nonmetastatic breast cancer and obesity

38. Exercise-induced modulation of monocytes in breast cancer survivors

39. Weight trajectories in women receiving systemic adjuvant therapy for breast cancer

40. Is 'Geriatric' Assessment Just for Older Patients?

41. Weight-Related Communications Between Oncology Clinicians and Women With Obesity at Early Breast Cancer Diagnosis: Findings From a Review of Electronic Health Records

42. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review

43. Establishing physical activity in breast cancer: self-report versus activity tracker

44. Inflammatory markers and overall survival in older adults with cancer

45. Social support and outcomes in older adults with lung cancer

46. Impact of community-based exercise program participation on aerobic capacity in women with and without breast cancer

47. Exercise training partially rescues impaired mucosal associated invariant t-cell mobilization in breast cancer survivors compared to healthy older women

48. Obesity, Weight Gain, and Weight Management

49. A single-arm feasibility trial of memantine to prevent chemotherapy-related cognitive decline in patients with early breast cancer

50. Healthy Behaviors: Prevalence of Uptake Among Cancer Survivors

Catalog

Books, media, physical & digital resources